Adrian Rawcliffe, Director at Wave Life Sciences Ltd. (WVE), sold 42,000 shares at $15.00 ($630K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($630k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2025-01-17 | $18K | — | Filing → |
| ADAP | SELL | 2025-01-15 | $35K | — | Filing → |
| ADAP | SELL | 2024-01-17 | $28K | — | Filing → |